UNC lab partnership develops first COVID-19 treatment approved by FDA
Posted Nov 7, 2020
Remdesivir, a drug developed through a partnership between UNC’s Baric Lab and Gilead Sciences, was recently approved as a COVID-19 treatment. As of Oct. 22, remdesivir is the first and only FDA-approved COVID-19 treatment in the U.S. UNC faculty and students reflected on the significance of remdesivir’s approval and what this means for the University.
(Daily Tar Heel)
Related: Campus Connections
Hannah Storm, Rich Eisen discuss impact Stuart Scott would have had todayCelebrated ESPN anchor Stuart Scott would have been 60 years old this year, and his former colleagues continue to mourn not only losing a friend...
Tue Mar 11, 2025Mack Brown Lists Nine-Bathroom Chapel Hill Home For Sale After Move to Austin
Former UNC football coach Mack Brown has listed his five-bedroom, nine-bathroom home in Chapel Hill for sale. The 9,913 square-foot mansion on Tenney Circle features...
Sat Mar 8, 2025
Fans, Franklin Street businesses excited as UNC, Duke face off to end regular season
Chapel Hill Sportswear is gearing up for crowds of its own this weekend. “It’s definitely been busier than a normal Friday, any other Friday,” said...
Sat Mar 8, 2025
Tailgate, Shrunken Head Boutique's expansion store, holds grand opening
On Feb. 28, Tailgate by Shrunken Head Boutique, located three doors down, hosted its grand opening. Tailgate is the extension of Shrunken Head Boutique, which...
Thu Mar 6, 2025
